Molina Healthcare, Inc.

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $16.81B
  • PE 15
  • Debt $2.33B
  • Cash $4.88B
  • EV $14.27B
  • FCF $94.00M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$1.14B
EBIT$1.64B
ROE24%
ROA10%
FCF$94.00M
Equity$4.77B
Growth Stability-597%
PE14.7
PEG1.39
PB3.53
P/FCF178.88
P/S0.43
Price/Cash0.29
Debt/Equity0.49
Debt/FCF24.81
Net Margins3%
Gross Margins16%
Op. Margins4%
Earnings CAGR26%
Sales Growth YoY21%
Sales Growth QoQ5%
Sales CAGR11%
FCF CAGR2%
Equity CAGR14%
Earnings Stability0.61
Earnings Growth YoY33%
Earnings Growth QoQ8%
Earnings CAGR 5Y11%
Sales CAGR 5Y20%
FCF CAGR 5Y-10%
Equity CAGR 5Y24%
Earnings CAGR 3Y12%
Sales CAGR 3Y12%
FCF CAGR 3Y-54%
Equity CAGR 3Y27%
Market Cap$16.81B
Revenue$39.20B
Assets$15.76B
Total Debt$2.33B
Cash$4.88B
Shares Outstanding57M
EV14.27B
Earnings Score88%
Moat Score86%
Safety Score42%
Final Score72%
Working Capital4.54B
Current Ratio1.55
Gross Profit$6.32B
Shares Growth 3y-0%
Equity Growth QoQ-2%
Equity Growth YoY23%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). In addition to its Health Plans segment, Molina has a Medicaid Solutions segment that provides solutions to U.S. state governments for their Medicaid management information systems. Molina's Medicaid plans receive revenue on a per-member per-month basis from state government agencies, and its Medicare Advantage plans receive revenue from managed care plans that contract with the Centers for Medicaid and Medicare (CMS). Molina also provides plans through health insurance exchanges.

SEC Filings

Direct access to Molina Healthcare, Inc. (MOH) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Molina Healthcare, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Molina Healthcare, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 26%
Stability 61%
loading chart...

Molina Healthcare, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Molina Healthcare, Inc..

= $1.1B
012345678910TV
fcf$94M$96M$98M$101M$103M$105M$108M$110M$113M$115M$118M$1.2B
DCF$87M$81M$76M$70M$65M$61M$56M$52M$49M$45M$454M
Value$1.1B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins1%1%0%-3%4%4%3%2%2%3%3%
ROA-6%4%-6%16%16%11%8%10%11%10%
ROE-9%3%-38%43%38%32%25%27%26%24%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-2.024.263.93-4.943.461.181.083.231.3924.81
Debt over Equity0.881.291.282.111.030.651.030.840.740.520.49
Growth Stability----597%-100%100%93%100%100%-597%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-47%25%12%-5%-11%15%43%15%7%20%
Earnings YoY growth-130%-64%-1K%-238%4%-9%-2%20%38%11%
Equity YoY growth-54%6%-19%23%19%7%25%13%42%24%
FCF YoY growth-5%-50%44%-148%-208%391%12%-67%131%-10%